ELEGEN

ELEGEN is a technology company specializing in synthetic biology, focusing on high-accuracy, long, and complex DNA synthesis through its proprietary cell-free technology. Their flagship product, ENFINIA DNA, provides industry-leading speed and quality for the synthesis of linear DNA, with applications in synthetic biology, gene therapy, and biomanufacturing. ELEGEN's cutting-edge methods facilitate rapid and reliable DNA production, eliminating early cloning steps to streamline workflows in various fields, including mRNA vaccine development, gene therapy, and agricultural genetics research.